Label-Free Imaging of Composite Hyaluronic Acid Hydrogels in Regenerative Medicine
再生医学中复合透明质酸水凝胶的无标记成像
基本信息
- 批准号:9389085
- 负责人:
- 金额:$ 38.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-06-01 至 2021-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAmyotrophic Lateral SclerosisAnimalsAntigensBehavioralBiocompatible MaterialsBiological MarkersBiological PreservationBlood VesselsCell SurvivalCell TransplantationCell TransplantsCellsCervicalChemicalsColorCuesDiffusionDimensionsDisease OutcomeDisease modelEncapsulatedEngraftmentEnvironmentFrequenciesGelGelatinGoldGreen Fluorescent ProteinsHandHumanHyaluronic AcidHydration statusHydrogelsHypoxiaImageImaging TechniquesImmune responseImplantIn VitroInjectableInjection of therapeutic agentKineticsLabelLongevityLuciferasesMagnetic Resonance ImagingMechanical StressMechanicsModificationMolecular StructureMonitorMusNear-infrared optical imagingNutrientNutritionalOptical reporterPolymersPrimary Lateral SclerosisPropertyRegenerative MedicineReporter GenesReportingSignal TransductionStem cell transplantStem cellsStudy modelsSulfhydryl CompoundsSurrogate MarkersSuspensionsTechniquesTestingTimeTissuesTransgenic AnimalsTransgenic OrganismsTransplantationTraumaTreatment EfficacyValidationWateradaptive immune responsebiomaterial compatibilitychemical propertycrosslinkimaging approachimaging modalityimaging studyimplantationimprovedin vivomechanical propertiesmouse modelnerve stem cellnoveloptical imagingphysical propertyprecursor cellresponsescaffoldtissue culture
项目摘要
Hydrogel scaffolds are increasingly being used as tissue-mimicking materials and as vehicles to improve
transplanted stem cell retention and survival. We have recently developed a new chemical exchange
saturation transfer (CEST) magnetic resonance imaging (MRI) method that is able to probe the in vivo stability
and gelatin decomposition of implanted composite hyaluronic acid (HA) hydrogels in a “label-free” fashion.
Compared to naked cells, we found that transplanted neural stem cells showed improved survival when
hydrogel scaffolding was applied. A major question that remains is the optimal mechanical properties of the
hydrogel, and how this relates to cell survival. At the one hand, for initial structural support, the gels should not
decompose too fast, but at the other hand they should at some point decompose to allow transplanted cells to
grow out and integrate with the surrounding host tissue. Our aim is to synthesize a range of composite near-
infrared (NIR)-HA hydrogels with different compositions and stabilities, to image their stability properties in
vivo, and to correlate the CEST/NIR optical imaging findings with cell survival as assessed using
bioluminescent imaging (BLI) as conventional readout. Using supercharged green fluorescent protein (sGFP)
as a new CEST MRI bimodal reporter gene, we will also investigate whether or not CEST MRI is able to probe
in vivo cell survival simultaneously. We have chosen to apply this approach to transplantation of glial-restricted
precursor cells (GRPs) in a transgenic amyotropic lateral sclerosis (ALS) mouse model, as we have found that
transplanted naked cells without hydrogel scaffolding survive poorly in the hostile ALS tissue environment.
水凝胶支架越来越多地被用作组织模拟材料和改善组织的载体
移植干细胞的保留和存活。我们最近开发了一种新的化学交换
饱和转移(CEST)磁共振成像(MRI)方法能够探测体内稳定性
以“无标记”方式植入复合透明质酸(HA)水凝胶的明胶分解。
与裸细胞相比,我们发现移植的神经干细胞在以下情况下表现出更高的存活率:
应用水凝胶支架。仍然存在的一个主要问题是该材料的最佳机械性能
水凝胶,以及它与细胞存活的关系。一方面,对于初始结构支撑,凝胶不应该
分解太快,但另一方面它们应该在某个时刻分解以允许移植的细胞
生长并与周围的宿主组织融合。我们的目标是合成一系列复合材料
具有不同成分和稳定性的红外 (NIR)-HA 水凝胶,以对其稳定性进行成像
体内,并将 CEST/NIR 光学成像结果与使用评估的细胞存活率相关联
生物发光成像(BLI)作为传统读数。使用增压绿色荧光蛋白 (sGFP)
作为新的CEST MRI双峰报告基因,我们还将研究CEST MRI是否能够探测
体内细胞同时存活。我们选择将这种方法应用于胶质限制性细胞的移植
转基因肌萎缩侧索硬化症(ALS)小鼠模型中的前体细胞(GRP),我们发现
没有水凝胶支架的移植裸细胞在恶劣的 ALS 组织环境中存活率很低。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeff W. Bulte其他文献
Jeff W. Bulte的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeff W. Bulte', 18)}}的其他基金
Precision magnetic hyperthermia by integrating magnetic particle imaging
通过集成磁粒子成像实现精确磁热疗
- 批准号:
10296182 - 财政年份:2021
- 资助金额:
$ 38.15万 - 项目类别:
Precision magnetic hyperthermia by integrating magnetic particle imaging
通过集成磁粒子成像实现精确磁热疗
- 批准号:
10667448 - 财政年份:2021
- 资助金额:
$ 38.15万 - 项目类别:
Precision magnetic hyperthermia by integrating magnetic particle imaging
通过集成磁粒子成像实现精确磁热疗
- 批准号:
10415219 - 财政年份:2021
- 资助金额:
$ 38.15万 - 项目类别:
Intracellular Self-Assembly of Theranostic Nanoparticles for Enhanced Imaging and Tumor Therapy
用于增强成像和肿瘤治疗的治疗诊断纳米颗粒的细胞内自组装
- 批准号:
10207626 - 财政年份:2020
- 资助金额:
$ 38.15万 - 项目类别:
Intracellular Self-Assembly of Theranostic Nanoparticles for Enhanced Imaging and Tumor Therapy
用于增强成像和肿瘤治疗的治疗诊断纳米颗粒的细胞内自组装
- 批准号:
10400220 - 财政年份:2020
- 资助金额:
$ 38.15万 - 项目类别:
Intracellular Self-Assembly of Theranostic Nanoparticles for Enhanced Imaging and Tumor Therapy
用于增强成像和肿瘤治疗的治疗诊断纳米颗粒的细胞内自组装
- 批准号:
10063659 - 财政年份:2020
- 资助金额:
$ 38.15万 - 项目类别:
Non-Invasive Tracking of Genome-Corrected iPS cells in ALS
对 ALS 中基因组校正的 iPS 细胞进行无创追踪
- 批准号:
10472760 - 财政年份:2019
- 资助金额:
$ 38.15万 - 项目类别:
Non-Invasive Tracking of Genome-Corrected iPS cells in ALS
对 ALS 中基因组校正的 iPS 细胞进行无创追踪
- 批准号:
10447292 - 财政年份:2019
- 资助金额:
$ 38.15万 - 项目类别:
Non-Invasive Tracking of Genome-Corrected iPS cells in ALS
对 ALS 中基因组校正的 iPS 细胞进行无创追踪
- 批准号:
9810637 - 财政年份:2019
- 资助金额:
$ 38.15万 - 项目类别:
Non-Invasive Tracking of Genome-Corrected iPS cells in ALS
对 ALS 中基因组校正的 iPS 细胞进行无创追踪
- 批准号:
10006002 - 财政年份:2019
- 资助金额:
$ 38.15万 - 项目类别:
相似海外基金
Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
- 批准号:
MR/Y014901/1 - 财政年份:2024
- 资助金额:
$ 38.15万 - 项目类别:
Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
- 批准号:
MR/Y014286/1 - 财政年份:2024
- 资助金额:
$ 38.15万 - 项目类别:
Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
- 批准号:
MR/Y503502/1 - 财政年份:2024
- 资助金额:
$ 38.15万 - 项目类别:
Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
- 批准号:
2317745 - 财政年份:2023
- 资助金额:
$ 38.15万 - 项目类别:
Standard Grant
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
- 批准号:
10759808 - 财政年份:2023
- 资助金额:
$ 38.15万 - 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
- 批准号:
10606865 - 财政年份:2023
- 资助金额:
$ 38.15万 - 项目类别:
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
- 批准号:
10696512 - 财政年份:2023
- 资助金额:
$ 38.15万 - 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
- 批准号:
10848139 - 财政年份:2023
- 资助金额:
$ 38.15万 - 项目类别:
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
- 批准号:
MR/Y001095/1 - 财政年份:2023
- 资助金额:
$ 38.15万 - 项目类别:
Fellowship
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
- 批准号:
488892 - 财政年份:2023
- 资助金额:
$ 38.15万 - 项目类别:
Operating Grants














{{item.name}}会员




